AGN-229666 Ophthalmic Solution in Japanese Patients With Allergic Conjunctivitis

Study Identifier
229666-006
CT.gov Identifier
NCT02161146
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Study Details

Medical Condition
  • Conjunctivitis
    • Study Drug
  • AGN-229666
  • Vehicle to AGN-229666
  • Olopatadine
    • Phase
    Phase 3
    Sex
    Female & Male
    Age
    20+ years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    -Japanese patients living in Japan with a history of allergic conjunctivitis.
    Exclusion Criteria:
    * Presence of active eye infection (bacterial, viral, or fungal) * History of an eye herpetic infection.

    Protocol Summary

    This study will evaluate the safety and efficacy of AGN-229666 for the prevention of allergen-mediated conjunctivitis.

    Study Locations

    Location
    Status
    Location
    Tokyo, Japan
    Status
    Not applicable